Cancer spread, called metastasis, is detected through a combination of symptoms, imaging scans, blood tests, and biopsies. No single test gives a definitive answer on its own. Instead, doctors piece together findings from multiple sources to determine whether cancer cells have moved beyond their original site and, if so, where they’ve gone.
Understanding what to watch for in your own body, and what your medical team is looking for in their tests, can help you stay informed at every step.
How Cancer Spreads in the First Place
Cancer cells don’t just appear in a new location randomly. Spread happens through a step-by-step process: cells break away from the original tumor, enter the bloodstream or lymphatic system, travel through the body, exit the blood vessels at a distant site, and establish a new tumor there. Along the way, these cells have to survive the immune system and find a hospitable environment to grow in.
Some organs are more vulnerable than others. The liver, for example, receives blood from two major sources, making it highly accessible to circulating cancer cells. Bones, lungs, and the brain are also common destinations. Where cancer tends to spread depends partly on blood flow patterns and partly on whether the new environment supports tumor growth. This is why certain cancers have predictable patterns: breast and prostate cancers frequently spread to bone, while colon cancer often reaches the liver first.
Symptoms That May Signal Spread
Some signs of metastasis are general and affect your whole body. These include extreme fatigue that doesn’t improve with rest, unexplained weight loss, and drenching night sweats. These symptoms alone don’t confirm spread, but when they appear alongside a known cancer diagnosis, they raise a flag worth investigating.
More telling symptoms depend on where the cancer has traveled.
Bone
Bone metastasis often causes deep, persistent pain in the affected area that may worsen at night or with activity. In some cases, bones weakened by cancer can fracture from minor stress. Cancer in the bones can also release excess calcium into the blood, leading to nausea, vomiting, constipation, and confusion.
Liver
When cancer reaches the liver, early symptoms can be subtle. As it progresses, you may notice yellowing of the skin or the whites of the eyes (jaundice), itchy skin, a bloated or swollen belly from fluid buildup, swelling in the legs, or pain in the upper right part of the abdomen.
Lungs
Cancer that has spread to the lungs can cause a persistent cough, shortness of breath, or chest pain. These symptoms often develop gradually and can be mistaken for other respiratory conditions.
Brain
Brain metastases produce neurological symptoms that vary depending on the tumor’s location. Headaches are the most common, but dizziness, blurred vision, weakness on one side of the body, difficulty walking, slurred speech, and even personality changes have all been documented. A review of lung cancer cases found that patients presented with symptoms ranging from persistent headaches and vision problems to limb weakness and confusion so severe they didn’t recognize family members. These symptoms are easily attributed to other causes, which can delay diagnosis.
Imaging Tests Used to Detect Spread
Imaging is usually the first step when doctors suspect metastasis. The type of scan depends on the original cancer and where spread is most likely.
CT scans use X-rays to create detailed cross-sectional images of the body and can reveal tumors in the lungs, liver, and other organs. MRI is particularly useful for examining the brain and spinal cord, where it provides high-resolution soft tissue images. Bone scans use a small amount of radioactive material to highlight areas of abnormal bone activity, though they can sometimes flag non-cancerous conditions like arthritis, leading to false alarms.
PET-CT scans combine two technologies. You receive an intravenous injection of a radioactive tracer that cancer cells absorb more readily than normal tissue, and this is overlaid on a CT image. The result is a whole-body map showing areas of unusual metabolic activity. For prostate cancer specifically, a newer type called PSMA PET-CT uses a tracer that binds to a protein abundant on prostate cancer cells. In clinical trials, PSMA PET-CT was 27% more accurate than the standard combination of CT and bone scans at detecting metastases (92% accuracy versus 65%), performing better for both lymph node involvement and distant spread to bone.
The Role of Lymph Node Testing
Lymph nodes act as filters throughout your body, and cancer cells that break away from a tumor often reach them first. This makes lymph node status one of the most important early indicators of whether cancer is on the move.
A sentinel node biopsy identifies the first lymph node (or nodes) that drain from the tumor site. During the procedure, a tracer is injected near the tumor to map which node receives drainage first. That node is removed and examined under a microscope. If it’s cancer-free, spread to other lymph nodes is unlikely and no further nodes need to be removed. If cancer is found, additional nodes may be taken out to determine the extent of involvement. This procedure is most commonly used in breast cancer and melanoma.
Blood Tests and Tumor Markers
Blood tests can provide clues about cancer activity, though they rarely confirm metastasis on their own. Tumor markers are substances, often proteins, that some cancers release into the bloodstream. Doctors track their levels over time: a rising marker after treatment can suggest the cancer is growing or has returned.
However, tumor markers have significant limitations. Not everyone with a given cancer produces elevated levels of the associated marker. And non-cancerous conditions can raise marker levels too. Because of this, marker results are always interpreted alongside imaging and other tests, never in isolation.
Liquid Biopsies: A Newer Approach
Liquid biopsies detect fragments of tumor DNA circulating in the blood. This technology is increasingly used after treatment to catch signs of cancer returning before it shows up on scans.
The results so far are striking. In colorectal cancer patients, detecting tumor DNA in blood after surgery predicted recurrence with 100% sensitivity, providing a warning an average of 9.4 months before standard blood markers flagged a problem. A large multi-center study found that liquid biopsies offered lead times of up to 14.4 months for lung cancer, 19.5 months for colorectal cancer, and 11 months for breast cancer before clinical evidence of recurrence appeared.
For early detection, a review of liquid biopsy studies in lung cancer reported 85% sensitivity and 90% specificity. This technology is also helping doctors make smarter treatment decisions. In a trial of stage II colon cancer patients, using liquid biopsy results to guide chemotherapy decisions meant fewer patients received unnecessary chemotherapy (15% versus 28%) without any increase in cancer recurrence.
How Staging Classifies Spread
Once testing is complete, doctors assign a stage using the TNM system. T describes the size of the original tumor, N indicates whether nearby lymph nodes are involved, and M records whether cancer has spread to distant parts of the body. Stage IV means distant metastasis has been confirmed, regardless of the tumor’s size or lymph node status.
Stage IV is further divided based on extent. Stage IVA means cancer has spread to one distant site or organ. Stage IVB means two or more distant sites are affected. Stage IVC indicates spread to the peritoneum, the membrane lining the abdominal cavity, which can occur alone or alongside other sites of metastasis. These distinctions help guide treatment planning and give a clearer picture of prognosis.
What the Testing Process Looks Like
If your doctor suspects cancer has spread, the evaluation typically starts with blood work and imaging. Which scans you get depends on your cancer type and symptoms. A patient with breast cancer and new back pain, for instance, would likely get a bone scan or PET-CT. Someone with colon cancer and abnormal liver enzymes would get abdominal imaging.
If imaging reveals suspicious areas, a biopsy of the new site may follow to confirm the cells match the original cancer. This distinction matters: cancer that started in the breast and spread to the liver is still breast cancer, not liver cancer, and is treated accordingly. The entire workup can take days to weeks depending on how many tests are needed and how quickly results come back. During this time, your medical team is assembling a complete picture before recommending next steps.